Benjamin Greenberg
Clene Inc., a Salt Lake City-based clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative disease, has appointed Dr. Benjamin Greenberg as head of medical. Greenberg is professor of neurology and vice chair of clinical and translational research in the Department of Neurology at UT Southwestern Medical Center in Dallas. His clinical and research activities focus on neurology, including the diagnosis and treatment of MS and other rare neurological disorders. Robert Glanzman, Clene’s current chief medical officer, will continue to serve the company in an advisory role.
